| BCBS Federal Medical & Drug | 5.50.005 NK1 Antagonists | 2025-06-12 |
| BCBS Federal Medical & Drug | 5.50.006 Opioid Antagonist Drug Class | 2025-06-12 |
| BCBS Federal Medical & Drug | 5.50.007 Viberzi (eluxadoline) | 2025-06-12 |
| BCBS Federal Medical & Drug | 5.50.014 Xermelo (telotristat ethyl) | 2025-06-12 |
| BCBS Federal Medical & Drug | 5.50.024 Motegrity (prucalopride) | 2025-06-12 |
| BCBS Federal Medical & Drug | 5.50.032 Livmarli (maralixibat) | 2025-06-12 |
| BCBS Federal Medical & Drug | 5.50.034 Rebyota | 2025-06-12 |
| BCBS Federal Medical & Drug | 5.50.035 Vowst (fecal microbiota, live-brpk) | 2025-06-12 |
| BCBS Federal Medical & Drug | 5.50.038 Voquezna (vonoprazan) | 2025-06-12 |
| BCBS Federal Medical & Drug | 5.55.001 Procysbi (cysteamine bitartrate) | 2025-06-12 |